ConductScience.org, home

Trial · NCT00502944

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

NCT00502944, Not applicable, Completed, Massachusetts General Hospital; results first posted 2012-07-13

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Two Approaches to Routine HIV Testing in a Hospital Emergency Department. Trials, record NCT00502944. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00502944

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Two Approaches to Routine HIV Testing in a Hospital Emergency Department
NCT number
NCT00502944
Status
Completed
Phases
Not applicable
Enrollment
4,855 participants, actual
Lead sponsor
Massachusetts General Hospital
Conditions
HIV Infections
Interventions
Counselor-based HIV screening, Emergency staff member-based HIV screening
First posted
2007-07-18
Last updated
2012-07-19
Results first posted
2012-07-13

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryLinkage to Care of Newly Diagnosed HIV Infected ParticipantsAssessed within 8 weeks after receipt of reactive rapid HIV test results
We define linkage to care as attendance at a first HIV clinic appointment where the following 3 events occur: 1) introduction to an HIV care primary provider; 2) receipt of confirmatory Western Blot HIV test results; and 3) phlebotomy for CD4 cell count and HIV RNA level.
SecondaryOverall Rapid HIV Testing RateAssess on day subject enrolled into the studyWe defined the overall rapid HIV testing rate as the number of participants tested for HIV using the rapid test among those randomized to potentially be tested in each arm.
OtherTest Offer RateAssess on day subject enrolled into the studyThe offer rate of the HIV test was defined as the proportion of enrolled study participants who were actually offered a test.
OtherTest Acceptance RateAssess on day subject enrolled into the studyAcceptance of the HIV test was defined as the proportion of study participants who received the HIV test among those offered the test.

Outcomes4

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
SECONDARYOverall Rapid HIV Testing RateAssess on day subject enrolled into the studyIntention to treat analysisparticipantsNUMBER
OTHER_PRE_SPECIFIEDTest Offer RateAssess on day subject enrolled into the studyparticipantsNUMBER
OTHER_PRE_SPECIFIEDTest Acceptance RateAssess on day subject enrolled into the studyNumber of participants analyzed equals the number of participants offered a rapid HIV test. Many participants left the ED before the opportunity was available to offer the test.participantsNUMBER
PRIMARYLinkage to Care of Newly Diagnosed HIV Infected ParticipantsAssessed within 8 weeks after receipt of reactive rapid HIV test resultsDSMB recommended the trial be ended early for likely inability to obtain this primary outcome. Thus the outcomes reported in paper are the secondary and other pre-specified outcomes listed.participantsNUMBER

Results by group10

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Overall Rapid HIV Testing RateCounselor1382participants
Overall Rapid HIV Testing RateProvider643participants
Test Offer RateCounselor1959participants
Test Offer RateProvider861participants
Test Acceptance RateCounselor1382participants
Test Acceptance RateProvider643participants
Linkage to Care of Newly Diagnosed HIV Infected ParticipantsCounselorPositive HIV Test0participants
Linkage to Care of Newly Diagnosed HIV Infected ParticipantsProviderPositive HIV Test7participants
Linkage to Care of Newly Diagnosed HIV Infected ParticipantsCounselorLinked to Care0participants
Linkage to Care of Newly Diagnosed HIV Infected ParticipantsProviderLinked to Care4participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCounselor2,446
Overall StudySTARTEDProvider2,409
Overall StudyCOMPLETEDCounselor1,382
Overall StudyCOMPLETEDProvider643
Overall StudyNOT COMPLETEDCounselor1,064
Overall StudyNOT COMPLETEDProvider1,766

Adverse events4

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherFalse-positive rapid test resultInvestigationsCounselor271,38227
otherFalse-positive rapid test resultInvestigationsProvider96439
otherSubject did not follow-up after reactive testInvestigationsCounselor61,3826
otherSubject did not follow-up after reactive testInvestigationsProvider56435

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityCounselor
Total, all-cause mortalityProvider
Total, other adverse eventsCounselor331,382
Total, other adverse eventsProvider14643
Total, serious adverse eventsCounselor01,382
Total, serious adverse eventsProvider0643

Papers13

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
18190295BACKGROUNDPubMed
18462591BACKGROUNDPubMed
18678842RESULTPubMed
19828278RESULTPubMed
19849965BACKGROUNDPubMed
20090953BACKGROUNDPubMed
20157472RESULTPubMed
20978834BACKGROUNDPubMed
21684391RESULTPubMed
21684408BACKGROUNDPubMed

1 to 10 of 13

See all 13 papers

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01MH073445Optimizing strategies for universal HIV testingWALENSKY, ROCHELLE P.MASSACHUSETTS GENERAL HOSPITALNATIONAL INSTITUTE OF MENTAL HEALTH2006 to 2010

Trial comparisons4

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Counselor vs Provider: Test Offer RateTrial comparisons
Counselor vs Provider: Overall Rapid HIV Testing RateTrial comparisons
Counselor vs Provider: Test Acceptance RateTrial comparisons
Counselor vs Provider: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00502944

GET https://conductscience.org/api/trials/v1/NCT00502944/registered